U.S. Stem Cell, Inc. USRM
At closeNov 11, 2026, 4:00 PM EST
- YTD
- 0.00%
- 1 year
- 0.00%
USRM free cash flow history
Free cash flow is operating cash flow minus capital expenditure outflow. It can be negative; it is not the same as earnings.
-304,852 USD
FY 2022 · Period ended
Coverage: stale. Values in USD; not inflation adjusted.
Capital expenditure is reported net of asset sales as an inflow for some periods; free cash flow is not shown for them.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Capital expenditure here is net of asset disposals, so free cash flow can be higher than a figure that subtracts gross purchases.
Missing observations.
Scroll the table to see all values →
| Fiscal period | Period end | Free cash flow | YoY change | YoY % |
|---|---|---|---|---|
| FY 2022 | 2022-12-31 | -304,852 | 753,087 | Not meaningful |
| FY 2021 | 2021-12-31 | -1,057,939 | -579,053 | Not meaningful |
| FY 2020 | 2020-12-31 | -478,886 | 732,108 | Not meaningful |
| FY 2019 | 2019-12-31 | -1,210,994 | -1,813,461 | -301.01% |
| FY 2018 | 2018-12-31 | 602,467 | Not available | Not available |
| FY 2017 | 2017-12-31 | Not available | Not available | Not available |
| FY 2016 | 2016-12-31 | 100,160 | 946,885 | Not meaningful |
| FY 2015 | 2015-12-31 | -846,725 | 270,043 | Not meaningful |
| FY 2014 | 2014-12-31 | -1,116,768 | 805,983 | Not meaningful |
| FY 2013 | 2013-12-31 | -1,922,751 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2025-01-04T21:03:05.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.